What are the potential risks and recommendations for patients on warfarin or direct oral anticoagulants, like apixaban, who travel internationally?
Abstract
Patients on warfarin or DOACs traveling internationally face bleeding and thrombotic risks, magnified by dietary changes and access issues. Regular monitoring and coordination with healthcare providers are recommended to manage these risks effectively during travel.
Fields of Study & Subjects
Atrial Fibrillation Management and Outcomes
Venous Thromboembolism Diagnosis and Management
Travel-related health issues
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 January 2026